Valuation: Augmedix, Inc.

Market Cap 116M 104M 96.77M 87.9M 165M 11.25B 167M 1.16B 454M 5.72B 436M 427M 18.38B P/E 2022
-2.39x
P/E 2023 -13.4x
Enterprise Value 95.78M 85.54M 79.8M 72.49M 136M 9.28B 138M 958M 375M 4.71B 360M 352M 15.16B EV / Sales 2022
1.75x
EV / Sales 2023 5.88x
Free-Float
99.74%
Yield 2022 *
-
Yield 2023 -
3 years 0.73
Extreme 0.73
6.25
5 years 0.73
Extreme 0.73
6.25
10 years 0.73
Extreme 0.73
10
Manager TitleAgeSince
Chief Executive Officer - 2024-10-01
Director of Finance/CFO - 2024-10-01
Chief Operating Officer - 2024-10-01
Director TitleAgeSince
Director/Board Member 63 2023-04-09
Director/Board Member - 2024-10-01
Date Insider Type Main position Quantity % Market Cap. Importance
10/2/24 Issuer sale

Chief Financial Officer

754,058 1.5256%
10/2/24 Issuer sale

Director

74,230 0.1502%
10/2/24 Issuer sale

Director

93,047 0.1882%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-53.47% 116M
+0.81%+4.24%+6.76%+60.00% 683B
+1.99%+2.82%+1.16%+60.18% 78.78B
-7.35%-5.41%+80.09%+998.55% 65B
+1.23%+1.55%+5.61%+140.23% 64.57B
+0.13%+3.69%-27.73%-5.07% 47.01B
-1.10%+1.61%-7.25%+72.11% 45.99B
+0.11%-1.01%+7.82%+26.43% 30.64B
-0.09%+3.17%+37.57%+54.87% 26.42B
+1.39%+1.23%-63.69%-59.83% 24.09B
Average -0.23%+2.72%+4.03%+129.40% 106.57B
Weighted average by Cap. +0.43%+3.24%+7.82%+115.96%

Financials

2022 2023
Net sales 30.93M 27.62M 25.77M 23.41M 44.05M 3B 44.48M 309M 121M 1.52B 116M 114M 4.9B 44.86M 40.06M 37.37M 33.94M 63.87M 4.34B 64.5M 449M 175M 2.21B 168M 165M 7.1B
Net income -24.45M -21.83M -20.37M -18.5M -34.82M -2.37B -35.16M -245M -95.64M -1.2B -91.8M -89.8M -3.87B -19.17M -17.12M -15.97M -14.51M -27.3M -1.86B -27.57M -192M -75M -943M -71.98M -70.42M -3.03B
Net Debt -4.28M -3.82M -3.56M -3.24M -6.09M -414M -6.15M -42.78M -16.73M -210M -16.06M -15.71M -677M -20.37M -18.19M -16.97M -15.42M -29.01M -1.97B -29.29M -204M -79.69M -1B -76.48M -74.82M -3.22B
Projected Income Statement - Annual - Augmedix, Inc.
Logo Augmedix, Inc.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Employees
1,430
  1. Stock Market
  2. Stocks
  3. AUGX Stock